Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer

Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer

Oncolytic viruses (OV) promote anti-tumour responses through the initiation of immunogenic cancer cell death which activates the host’s systemic anti-tumour immunity. We have previously shown that intravenously administered HSV1716 is an effective treatment for mammary cancer. However, intravenous a...

Полное описание

Библиографические подробности
Главные авторы:	Amy Kwan, Faith Howard, Natalie Winder, Emer Atkinson, Ameera Jailani, Priya B. Patel, Richard Allen, Penelope D. Ottewell, Gary C. Shaw, Joe Conner, Caroline Wilson, Sanjay K. Srivastava, Sarah J. Danson, Claire Lewis, Janet E. Brown, Munitta Muthana
Формат:	Статья
Язык:	English
Опубликовано:	MDPI AG 2022-10-01
Серии:	Future Pharmacology
Предметы:	breast cancer macrophages cell carrier oncolytic virus HSV1716
Online-ссылка:	https://www.mdpi.com/2673-9879/2/4/29

Схожие документы

HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib <i>In Vitro</i> and Significantly Reduces Systemic Tumor Growth in Mouse Models
по: Simon Tazzyman, и др.
Опубликовано: (2023-02-01)

Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability
по: Faith Howard, и др.
Опубликовано: (2022-06-01)

Targeting Cancers with oHSV-Based Oncolytic Viral Immunotherapy
по: Rakin Tammam Nasar, и др.
Опубликовано: (2024-06-01)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
по: Elizabeth Robilotti, и др.
Опубликовано: (2023-09-01)

Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus
по: Jun Ding, и др.
Опубликовано: (2022-10-01)

Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response
по: Kevin A. Cassady, и др.
Опубликовано: (2009-10-01)

HSV: The scout and assault for digestive system tumors
по: Sheng Li, и др.
Опубликовано: (2023-02-01)

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
по: Braidwood L, и др.
Опубликовано: (2014-10-01)

High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy
по: Leslee Sprague, и др.
Опубликовано: (2018-03-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
по: Irene Appolloni, и др.
Опубликовано: (2021-08-01)

An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma
по: Alberto Reale, и др.
Опубликовано: (2024-09-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
по: Ifeanyi Kingsley Uche, и др.
Опубликовано: (2021-06-01)

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
по: Amy Kwan, и др.
Опубликовано: (2021-06-01)

Novel Steroidal[17,16-<i>d</i>]pyrimidines Derived from Epiandrosterone and Androsterone: Synthesis, Characterization and Configuration-Activity Relationships
по: Fei Yang, и др.
Опубликовано: (2023-03-01)

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines
по: Ifeanyi Kingsley Uche, и др.
Опубликовано: (2022-01-01)

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability
по: Edward M. Kennedy, и др.
Опубликовано: (2020-09-01)

‘I am happy that Italy fosters such exquisite minds’. Gijsbert Cuper (1644-1716) and intellectual life on the Italian peninsula
по: Jetze Touber
Опубликовано: (2015-12-01)

oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy
по: Upasana Sahu, и др.
Опубликовано: (2023-06-01)

Leibniz : an introduction /
по: 213617 Broad, Charlie Dunbar
Опубликовано: (1975)

Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
по: Ravi N. Samy, и др.
Опубликовано: (2019-10-01)

STING activator 2′3′‐cGAMP enhanced HSV‐1‐based oncolytic viral therapy
по: Patricia Angela Sibal, и др.
Опубликовано: (2024-05-01)

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
по: Xin Xie, и др.
Опубликовано: (2022-01-01)

Proliferating Cell Nuclear Antigen in the Era of Oncolytic Virotherapy
по: Amy Kwan, и др.
Опубликовано: (2024-08-01)

A new algorithm for multiplication in finite fields
Опубликовано: (2003)

The philosophy of Leibniz : metaphysics and language /
по: Mates, Benson, 1919-
Опубликовано: (c198)

Analysis of HSV1/2 Infection Reveals an Association between HSV-2 Reactivation and Pregnancy
по: Sara Dovrat, и др.
Опубликовано: (2024-08-01)

Exploiting non-permissive CHO cells as a rapid and efficient method for recombinant HSV-1 isolation
по: Mishar Kelishadi, и др.
Опубликовано: (2024-05-01)

Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines
по: Shahriyar Abdoli, и др.
Опубликовано: (2019-01-01)

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
по: Sara Shayan, и др.
Опубликовано: (2022-04-01)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
по: Amanda M. Casto, и др.
Опубликовано: (2020-08-01)

Thomas Gray Archive
по: Huber, A
Опубликовано: (2018)

Untreated HSV Leading to Neonatal Death
по: Meghan Sawyer, и др.
Опубликовано: (2025-02-01)

Perspectives on immunotherapy via oncolytic viruses
по: Alberto Reale, и др.
Опубликовано: (2019-02-01)

USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells
по: Ruitao Lu, и др.
Опубликовано: (2021-12-01)

Editorial: Oncolytic virotherapy, volume II
по: Ahmed Majeed Al-Shammari, и др.
Опубликовано: (2025-01-01)

Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes
по: Deng J, и др.
Опубликовано: (2024-08-01)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
по: Poorna Goswami, и др.
Опубликовано: (2022-05-01)

A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition
по: Joshua D. Bernstock, и др.
Опубликовано: (2019-12-01)

Improved antitumor effectiveness of oncolytic HSV-1 viruses engineered with IL-15/IL-15Rα complex combined with oncolytic HSV-1-aPD1 targets colon cancer
по: Zongfeng Hu, и др.
Опубликовано: (2024-10-01)

Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties
по: Sherif T. S. Hassan, и др.
Опубликовано: (2019-08-01)